Johannes Baillou elected Chairman of the Family BoardProfessor Dr. Simon Thelen elected Vice Chairman of the Family Board and Board of PartnersDr. Wolfgang Büchele elected Chairman of the Board of Partners

E. Merck KG, Darmstadt, Germany, the company through which the Merck family holds around 70 percent of Merck KGaA, Darmstadt, Germany, today announced the results of its regular board elections held this past weekend.

Johannes Baillou (58) was elected Chairman of the Family Board, which represents the Merck family’s entrepreneurial interests. Baillou has 30 years of Board experience at E. Merck KG, Darmstadt, Germany. First elected to the Family Board in 1994, he became Vice Chairman of the Board of Partners in 2009 and Chairman in 2014. That year, he was also elected Vice Chairman of the Family Board and Executive Board of E. Merck KG, Darmstadt, Germany.  

Johannes Baillou succeeds Dr. Frank Stangenberg-Haverkamp (75), with whom he has worked side by side for ten years and who has reached the mandatory retirement age. He had been Chairman of the Family Board and Executive Board of E. Merck KG, Darmstadt, Germany, since 2014.

Professor Dr. Simon Thelen (44) was elected Vice Chairman of the Family Board and Board of Partners of E. Merck KG, Darmstadt, Germany. He has been a member of the Board of Partners since 2019 and was first elected its Vice Chairman in 2021. Thelen is a physician specializing in hand surgery and an adjunct professor of medicine.

“Dr. Frank Stangenberg-Haverkamp has devoted four decades of service to Merck KGaA, Darmstadt, Germany,” said Johannes Baillou. “The partners thank him wholeheartedly for the clarity, courage and care with which he has guided our company and led our family. At the same time, I am delighted that with Professor Dr. Simon Thelen, the next generation of our family is increasingly seizing the opportunity to shape the future of our company and continuing a practice that is now in the 12th generation. This underscores the family’s unwavering commitment.”

In addition to the new Chairman Johannes Baillou, the family elected their 11 further representatives to the Family Board.

The Family Board, in turn, elected the nine members of the Board of Partners of E. Merck KG, Darmstadt, Germany, which is comparable to the supervisory board of a German stock corporation (Aktiengesellschaft) and is composed of family members as well as non-family members.

Dr. Wolfgang Büchele (64) was elected Chairman of the Board of Partners. “Dr. Wolfgang Büchele brings a wealth of industrial and entrepreneurial experience. As an external and independent advisor to our company for the past 15 years in his roles as Chairman of the Supervisory Board of Merck KGaA, Darmstadt, Germany, and member of the Board of Partners of E. Merck KG, Darmstadt, Germany, he understands our company very well,” said Johannes Baillou.

Consequently, Dr. Wolfgang Büchele will step down as Chairman and member of the Supervisory Board of Merck KGaA, Darmstadt, Germany, prior to this year’s Annual General Meeting. The Supervisory Board will elect a new Chair without delay.

The following representatives were elected to the Board of Partners:

Family representatives:

Johannes Baillou (58), Dr. Katharina Kraft (41), Carl Christoph Schweickert (42), Dr. Daniel Thelen (49), Prof. Dr. Simon Thelen (44)

External and independent representatives:

Dr. Wolfgang Büchele (64), Michael Kleinemeier (66), Dr. Susanne Schaffert (57), André Wyss (56)